SCHEMBL29452905

SCHEMBL29452905

O=C1CNCCN1Cc1cccc(Br)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
MEN1 O00255 1/20 0.44
POLB P06746 1/20 0.44
KMT2A Q03164 1/20 0.44
MAPT P10636 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
KDM4E B2RXH2 1/20 0.43
ADORA2A P29274 2/20 0.42
ADORA1 P30542 2/20 0.42
MBTD1 Q05BQ5 1/20 0.42
L3MBTL3 Q96JM7 1/20 0.42
MAOB P27338 2/20 0.41
KCNN4 O15554 1/20 0.41
SIRT2 Q8IXJ6 1/20 0.41
SIRT1 Q96EB6 1/20 0.41
CA12 O43570 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4694508 0.82 CYP2C9 (0.67) TDP1MEN1POLBKMT2AMAPT
SCHEMBL3154100 0.82 POLB (0.67) TDP1MEN1POLBKMT2AMAPT
SCHEMBL25271016 0.81 ALDH1A1 (0.42) SMN1; SMN2POLBKDM4E
Hydrochloric Acid SCHEMBL6417883 0.81 SLC6A2 (0.44) MEN1POLBKMT2AMAPTCYP2C9
SCHEMBL92331 0.81 L3MBTL1 (0.56) MEN1POLBKMT2AMAPTCYP2C9
SCHEMBL3033992 0.80 POLB (0.68) SMN1; SMN2TDP1MEN1POLBKMT2A
SCHEMBL3906515 0.80 SLC6A2 (0.47) MEN1POLBKMT2AMAPTCYP2C9
Bromide SCHEMBL28426487 0.80 L3MBTL1 (0.54) MEN1POLBKMT2AMAPTCYP2C9
Hydrochloric Acid SCHEMBL4768580 0.80 L3MBTL1 (0.54) MEN1POLBKMT2AMAPTCYP2C9
Hydrochloric Acid SCHEMBL6886546 0.79 SLC6A2 (0.46) MEN1POLBKMT2AMAPTCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108250058-B PPAR agonists and their use in the treatment of Alzheimer's disease and other diseases 上海怡立舍生物技术有限公司 2022-02-11 CN disclosed